UPDATE: Warfarin Genetic Testing Decreases Hospitalization Rate, Study Finds

Research presented at the American College of Cardiology scientific session in Atlanta today suggests individuals who receive genetic testing early in their warfarin treatment are up to 31 percent less likely to be hospitalized than those who don't.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.